Steady-State Optimal Insulin Infusion for Hyperglycemic ICU Patients J G Chase, G C Wake, Z-H Lam, J-Y Lee, K-S Hwang and G. Shaw University of Canterbury.

Slides:



Advertisements
Similar presentations
Chapter 4: Basic Properties of Feedback
Advertisements

(ex) Consider a plant with
Professor Walter W. Olson Department of Mechanical, Industrial and Manufacturing Engineering University of Toledo Laplace Transforms.
MODELING METHOD Glucose-Insulin System Model CLINICAL DATA DATA: Are taken from the SPRINT [3] TGC cohort totalling 393 patients and ~40,000 patient hours.
Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.
AMI 4622 Digital Signal Processing
Improved Modeling of the Glucose-Insulin Dynamical System Leading to a Diabetic State Clinton C. Mason Arizona State University National Institutes of.
Insulin initiation OPTIMISING Glycaemic control and Weight Dr C Rajeswaran Consultant Physician Diabetes & Endocrinology Mid Yorkshire NHS Trust.
Continuous Glucose Monitoring
Transient and steady state response (cont.)
Lecture 14: Laplace Transform Properties
Blood Glucose Regulation BIOE Glucose Regulation Revisited input: desired blood glucose output: actual blood glucose error: desired minus measured.
What is Diabetes? Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively.
Diabetes Mellitus “A Brief Introduction” Presented by Rainsville Family Practice Thomas L. Horton, MD.
An example of a critical system
ECE 8443 – Pattern Recognition ECE 8423 – Adaptive Signal Processing Objectives: Adaptive Noise Cancellation ANC W/O External Reference Adaptive Line Enhancement.
Laplace transformation
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Interactions between the Liver and Pancreas. Explain the control of blood glucose concentration, including the roles of glucagon, insulin and α and β.
Ch 8.1 Numerical Methods: The Euler or Tangent Line Method
Clinical Validation of a Model-based Glycaemic Control Design Approach and Comparison to Other Clinical Protocols J.G. Chase et al Dept of Mechanical Engineering.
Machine Learning Models for Blood Glucose Prediction in Diabetes Management PI: Cindy Marling Co-PIs: Razvan Bunescu and Frank Schwartz, MD This illustration,
Highly Correlated Measures of Insulin Sensitivity Thomas Lotz 1, J Geoffrey Chase 1, Kirsten A McAuley 3, Jessica Lin 1, Geoffrey M Shaw 2, Chris E Hann.
Identification of Time Varying Cardiac Disease State Using a Minimal Cardiac Model with Reflex Actions 14 th IFAC SYMPOSIUM ON SYSTEM IDENTIFICATION, SYSID-2006.
We could know the results before the trial starts… JG Chase Centre for Bio-Engineering University of Canterbury New Zealand T Desaive Cardiovascular Research.
INTRODUCTION Stress-induced hyperglycaemia is common in critical care 1 Hyperglycaemia worsens patient outcomes, increasing risk of infection 2, myocardial.
Diabetes Mellitus For high school and college students By Emily Freedman A disease that disrupts normal metabolism, interfering with cells’ ability to.
The Patient Undergoing Surgery: Proven Steps to Better Outcomes Ariel U. Spencer, MD Lafayette Surgical Clinic Lafayette, Indiana.
Real-time control Model-Based Blood Glucose Control for Neonatal Intensive Care Engineering robust solutions for our most fragile infants Background and.
Active Insulin Infusion Control of the Blood Glucose Derivative J G Chase, Z-H Lam, J-Y Lee and K-S Hwang University of Canterbury Dept of Mechanical Engineering.
INTRAVENOUS INFUSION.
Validation of a Virtual Patient and Virtual Trials Method for Accurate Prediction of TGC Protocol Performance F Suhaimi 1,5, A.J. LeCompte 1, S Penning.
INTEGRAL-BASED IDENTIFICATION OF A PHYSIOLOGICAL INSULIN AND GLUCOSE MODEL ON EUGLYCAEMIC CLAMP AND IVGTT TRIALS T Lotz 1, J G Chase 1, K A McAuley 2,
TEMPLATE DESIGN © The impact of MC error (with and without shown): Figure 5: A sample fit comparison with and without.
Diabetes mellitus (DM), also known simply as diabetes, is a group of metabolic diseases in which there are high blood sugar levels over a prolonged period.
A HIGHLY CORRELATED METHOD TO ASSESS INSULIN RESISTANCE IN BROAD POPULATIONS T Lotz 1 J G Chase 1, KA McAuley 2, GM Shaw 3, CE Hann 1, JI Mann 2 1 Department.
Introduction Clinical Setting - Glucoregulatory system - Patients and Data Assessment Proc. - Glucose sensors - Glycemia control system Control System.
Chronic elevation of blood glucose levels leads to the endothelium cells taking in more glucose than normal damaging the blood vessels. 2 types of damage.
Tight Glucose Control in Critically Ill Patients Using a Specialized Insulin- Nutrition Table Development Implementation of the SPRINT Protocol T. Lonergan,
Long Term Verification of Glucose-Insulin Regulatory System Model Dynamics THE 26th ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 4.
Optimising Ventilation Using a Simple Model of Ventilated ARDS Lung Geoffrey M Shaw 1, J. Geoffrey Chase 2, Toshinori Yuta 2, Beverley Horn 2 and Christopher.
ABSTRACT Hyperglycaemia is prevalent in critical care, and tight control reduces mortality. Targeted glycaemic control can be achieved by frequent fitting.
THE LAPLACE TRANSFORM LEARNING GOALS Definition
14th IFAC (International Federation of Automatic Control) Symposium on System Identification, SYSID 2006, March IMPACT OF SYSTEM IDENTIFICATION METHODS.
DERIVATIVE WEIGHTED ACTIVE INSULIN CONTROL ALGORITHMS AND TRIALS J. Geoffrey Chase, Geoffrey M. Shaw, Carmen V. Doran, Nicolas H. Hudson and Katherine.
INSULIN By Sarah Marknette. WHAT IS IT?  “Insulin is necessary for normal carbohydrate, protein, and fat metabolism. People with type 1 diabetes mellitus.
Blood glucose level 1/Regulation of blood glucose levels - high levels of blood glucose - low levels of blood glucose 2/ Effect of chronic elevated blood.
“Diabetes” When blood sugar is out of control. What happens if the body can’t handle carbs normally? One result is diabetes. This can be detected by a.
A FULLY IDENTIFIABLE PHYSIOLOGICAL MODEL OF INSULIN KINETICS FOR CLINICAL APPLICATIONS T Lotz 1, J G Chase 1, S Andreassen 2, C E Hann 1, J Lin 1, J Wong.
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57) Last modified January 2015.
Lecturer: Bahiya Osrah.  It is a chronic disease associated with hyperglycemia (increased blood glucose level) & glucourea (presence of glucose in urine)
Do Now (no sheet today) Pick up a laptop for yourself Open school website.
Learning from the Past, Looking to the Future James R. (Jim) Beaty, PhD - NASA Langley Research Center Vehicle Analysis Branch, Systems Analysis & Concepts.
Math for CS Fourier Transforms
Class 3 Linear System Solution Using the Laplace Transform
DEVELOPED IN PART BY THE COMMUNITY WELLNESS TEAM Diabetes GETTING STARTED.
Identification of Patient Specific Parameters for a Minimal Cardiac Model THE 26th ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE.
Exercise 1 Suppose we have a simple mass, spring, and damper problem. Find The modeling equation of this system (F input, x output). The transfer function.
Modeling and Simulation Dr. Mohammad Kilani
Blood Glucose Muthana A. Al-Shemeri.
NUTRITION AND FITNESS LIFESYTLE CHANGE PROGRAM
Faster-Acting Insulins
Glucose Tolerance Test Physiology lab-3 February, 2018
Insulin: understanding its action in health and disease
Diabetes and Exercise.
A whole body model for both glucose and fatty acid metabolism
Lecture 6: Time Domain Analysis and State Space Representation
Blood/Subcutaneous Glucose Dynamics Estimation Techniques
Interactions Among Animal Systems (Part One)
Presentation transcript:

Steady-State Optimal Insulin Infusion for Hyperglycemic ICU Patients J G Chase, G C Wake, Z-H Lam, J-Y Lee, K-S Hwang and G. Shaw University of Canterbury Dept of Mechanical Engineering Christchurch New Zealand ICARCV 2002, Singapore

Diabetes – A Brief Overview Diabetes – A disorder of the metabolism –Type I: Body produces little or no insulin. –Type II: Insulin resistance or impaired glucose tolerance. Complications – kidney failure, blindness, nerve damage, amputation, heart attack, stroke. High annual costs growing exponentially with number of cases Estimated cost to NZ is $1B per year in 2020 – A growing epidemic! –Similar numbers hold true throughout most of the world, including Singapore.

Diabetes in the ICU Elevated blood glucose levels or Hyperglycaemia is very common among the critically ill in the ICU –Stress of the disease –Many older patients are Type II diabetic individuals –Direct result of disease Current Treatment –Sliding scale protocols based on magnitude with very coarse resolution –Feeding 1-2x daily in slow infusion –Generally poor control (<8 mmol/L is considered “very good”) –Often overlooked because of severity of other issues and disease Why bother? 45 reasons for every 100! –Vandenberghe et al (2001) showed that tight glucose regulation in the ICU (levels < 6mmol/L) resulted in up to a 45% decrease in mortality

3 Elements of Control Systems in an ICU Sensing –Typically done with GlucoCard™ or similar arterial blood measurement –Modern methods of automatic measuring being developed (Trajanoski et al, 1994) Computation –Sliding scale protocol could be replaced by an algorithm implemented on DSP Actuation –Standard systems such as a Graseby 3500 Necessary technologies emerging very rapidly to close the loop!

Model derived and validated in “Bergman et al.” [1985] –More amenable for real-time control analysis than many models G and I are variations from basal levels of Glucose and Insulin. Coefficients p1, p2, p3 vary for Type I, Type II, Normal, and n varys for insulin type. System simulated with time step of 1 minute, actuation and sensor bandwidth are varied to determine trade-offs and diminishing returns. 2-Compartment Glucose-Insulin System Model

Optimal Steady State Infusion Rate Equations for I(t) and X(t) solved analytically and the optimal solution for u(t) obtained for G = d/dt(G) = 0 – no excursion or slope Solution depends on 1 st and 2 nd derivatives of exogenous glucose input P(t) as well as its initial conditions. I.e. you must know P(t) very well. If P(t)=0 for all t then the optimal steady state rate is simply u0 as expected for G=d/dt(G)=0 status

Solution of Steady State Optimal Infusion I First solve for I(t) insulin level in first compartment in terms of infusion u(t) Use I(t) solution to obtain remote compartment analytical solution for X(t) in terms of the input u(t) from the solution for I(t).

Solution of Steady State Optimal Infusion II Insulin utilization equation if dG/dt = G = 0 for a Type 1 diabetic  the steady state Inserting solutions for X(t) and using Laplace transforms to simplify the convolution integrals and algebra the steady state optimal infusion u(t) can be obtained from the inverse Laplace transform of the above equation solved for U(s) The algebra is “ugly” but fairly direct and much easier if the initial conditions for P(t) are equal to zero, which should be true for a slow, smooth infusion.

Optimal Control of a Glucose Slow Infusion Infusion will “follow” the normal response shown Optimal response essentially flat because P(t) is very well known, smooth and continuous This input profile is not unlike a typical ICU night feeding via IV. Infusion occurs over ~3hours for 500kcals of feeding The optimal controller handles this case very well

Optimal Infusion for Slow Infusion Glucose Response is ~ flat with small errors due to numerical time step size. At infinitely small size the response is almost perfectly flat. Small negative infusion or glucose input is due to numerical issues. The solution is not very stable on Matlab Much more like an injection than the normal modeled response.

A Difficult Test 1000 calories in 4 hours over five “meal” inputs of glucose which is rapidly absorbed Inputs vary in magnitude from 50 – 400 calories Inputs occur in two groups of rapid succession at t = 0, 10, 30 minutes and at t = 210 and 300 minutes –The last meal is 40 calories from 980 – 1020 calories so the full absorption of about 1000 calories occurs by 4 hours quite easily. Controller has no knowledge of glucose input except in optimal case –Input knowledge is not currently practicable in any way for this system in general The goal is to “hammer” the system and see if it breaks!

Comparison with other Controllers Optimal steady state infusion rate by solving analytically with Relative proportional controller (RPC). PD controller – controls slopes of incresing/decreasing blood sugar level rather than actual glucose concentration

Control of Glucose Inputs Optimal control very nearly flat as desired and much lower than other forms of control

Insulin Infusion Rates for Glucose Inputs Insulin rates are sharper and nearer injections expected Lower insulin rates less effective control as might be expected Total insulin used is very similar for each case  better usage w/ optimal

Summary & Conclusions A steady state optimal infusion solution is developed for a physiologically verified 3 compartment model of the glucose regulatory system Solution is shown to provide the desired ~flat glucose response to steady, slow inputs as well as more significant challenges Optimal solution does require knowledge of the glucose absorption function P(t) which is unlikely to be known outside of a controlled setting such as the ICU. Hence, it’s limited application clinically. Optimal insulin infusions mimic the injection solutions which have been hand optimized for care over the prior 50+ years

Acknowledgements… Lipids and Diabetes Research Group

“Failure is not an option (but it is much more interesting).” -- G. Shaw, MD “No, no, no… (explicit adjective(s))” -- G. Chase, PhD Questions, Comments, “Complements”, ….